Cho, Hee Jin
Yun, Kum-Hee http://orcid.org/0009-0006-5268-3191
Shin, Su-Jin
Lee, Young Han
Kim, Seung Hyun http://orcid.org/0000-0002-3878-1944
Baek, Wooyeol http://orcid.org/0000-0002-6638-4110
Han, Yoon Dae
Kim, Sang Kyum
Ryu, Hyang Joo
Lee, Joohee
Cho, Iksung
Go, Heounjeong http://orcid.org/0000-0003-0412-8709
Ko, Jiwon
Jung, Inkyung http://orcid.org/0000-0003-3780-3213
Jeon, Min Kyung
Rha, Sun Young http://orcid.org/0000-0002-2512-4531
Kim, Hyo Song http://orcid.org/0000-0002-0625-9828
Funding for this research was provided by:
National Research Foundation of Korea (2021R1A2C1094530, RS-2023-00209741)
Yonsei University | Yonsei University College of Medicine (6-2019-0187)
Article History
Received: 2 June 2023
Accepted: 9 January 2024
First Online: 23 January 2024
Competing interests
: H.S.K. received grant/research support from MSD, Eli Lilly and Company, Ono Pharmaceutical Company, Medpacto Pharmaceutical, and Boryung Pharmaceutical Company outside the submitted work. S.Y.R. received grant/research support from MSD, Celltrion, Boehringer-Ingelheim, Eli Lilly and Company, Taiho, Bristol-Myers Squibb, ASLAN, and Incyte; consultation fees for Daiichi Sankyo, MSD, Eli Lilly, Bristol-Myers Squibb, and Eisail; and served on a speaker’s bureau for Eli Lilly, Bristol-Myers Squibb, and MSD outside the submitted work. All remaining authors declare no competing interests.